|
🐜
|
An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.
15 auth.
H. Zou,
Qiuhua Li,
Joseph H. Lee,
M. Arango,
S. McDonnell,
S. Yamazaki,
T. Koudriakova,
G. Alton,
J. Cui,
P. Kung,
...
M. Nambu,
G. Los,
S. Bender,
B. Mroczkowski,
J. Christensen
|
9 |
2007 |
9
🐜
|
|
🐜
|
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
10 auth.
J. Christensen,
H. Zou,
M. Arango,
Qiuhua Li,
Joseph H. Lee,
S. McDonnell,
...
S. Yamazaki,
G. Alton,
B. Mroczkowski,
G. Los
|
9 |
2007 |
9
🐜
|
|
🐜
|
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations
23 auth.
H. Zou,
Qiuhua Li,
Lars D. Engstrom,
Melissa West,
Vicky A. Appleman,
K. Wong,
M. McTigue,
Ya-Li Deng,
Wei Liu,
A. Brooun,
...
Sergei L. Timofeevski,
S. McDonnell,
P. Jiang,
M. D. Falk,
P. Lappin,
T. Affolter,
T. Nichols,
Wenyue Hu,
Justine L. Lam,
T. Johnson,
T. Smeal,
A. Charest,
V. Fantin
|
7 |
2015 |
7
🐜
|
|
🐜
|
Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
14 auth.
Helen Cho,
S. Black,
D. Looper,
Manli Shi,
D. Kelly-Sullivan,
Sergei L. Timofeevski,
K. Siegel,
Xiao-hong Yu,
S. McDonnell,
Ping Chen,
...
J. Yie,
K. Ogilvie,
James W. Fraser,
C. Briscoe
|
4 |
2008 |
4
🐜
|
|
🐜
|
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance
9 auth.
Jennifer L. Green,
R. Osterhout,
Amy L. Klova,
Carsten Merkwirth,
S. McDonnell,
R. B. Zavareh,
...
B. Fuchs,
A. Kamal,
J. Jakobsen
|
3 |
2021 |
3
🐜
|
|
🐬
|
LPS-induced biomarkers in mice: a potential model for identifying insulin sensitizers.
C. Briscoe,
D. Looper,
P. Tran,
J. Herrera,
S. McDonnell,
B. Bhat
|
2 |
2007 |
2
🐬
|
|
🐬
|
Abstract 5857: Molecular characterization of response to interferon alpha in sensitive and resistant bladder cancer models
R. Osterhout,
Jennifer A Green,
S. McDonnell,
Amy L. Klova,
A. Kamal
|
0 |
2020 |
0
🐬
|
|
🐢
|
Abstract 588: Characterization of oncolytic peptides for local bladder cancer therapy
7 auth.
Amy L. Klova,
Hiroe Tariga,
Suijin Yang,
A. Velentza,
J. Stalewski,
A. Kamal,
...
S. McDonnell
|
0 |
2020 |
0
🐢
|
|
🐬
|
Comparative response of bladder cancer models to interferon alpha: Recombinant protein versus adenoviral delivery.
Jennifer A Green,
R. Osterhout,
S. McDonnell,
Amy L. Klova,
A. Kamal
|
0 |
2020 |
0
🐬
|
|
🦁
|
The Role of NPM-ALK Signaling in Tumor Cell Metabolism.
S. McDonnell
|
0 |
2013 |
0
🦁
|
